Xizang Weixinkang Pharmaceutical Co., Ltd.

Founded in 2002 and formally established in 2006, Weixinkang Pharmaceutical was officially renamed as Tibet Weixinkang Pharmaceutical Co. The company is a comprehensive high-tech pharmaceutical enterprise integrating R&D, production and sales of drugs, with significant advantages in the fields of intravenous vitamins, intravenous trace elements and intravenous electrolytes. Our leading products include multivitamin for injection (12), multivitamin for pediatric injection (13), multi-trace element injection, compound amino acid injection (20AA), pediatric compound amino acid injection (19AA-Ⅰ), acetylcysteine solution for inhalation, potassium magnesium menthylate for injection, iron sucrose injection, compound electrolyte injection (II), compound electrolyte injection (V), mixed sugar electrolyte (V), mixed sugar electrolyte injection and many other products. The company has established a professional and efficient marketing and sales network, and its business system has covered more than 3,000 secondary and above terminal medical institutions nationwide, covering the mainstream commercial channels and most of the provinces. The company has always adhered to the talent concept of "people-oriented and excellence", which has attracted a large number of professional talents to join the company, laying a solid foundation for the long-term development of the company. In the future, Weixin Kang will continue to adhere to the corporate mission of "Caring for life and maintaining health", rooted in China, facing the world, focusing on the health business, focusing on cutting-edge fields, further responding to the development trend of the pharmaceutical industry, and continuously improving its innovation capability.